애브비(주)
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionTIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund
Latest Disclosed Ownership80 shares
Latest Disclosed Value $ 14,849
TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund reports 97.15% decrease in ownership of ABBV / AbbVie Inc.

On August 27, 2025 - TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund filed a NPORT-P form disclosing ownership of 80 shares of AbbVie Inc. (US:ABBV) valued at $14,850 USD as of June 30, 2025. The entity filed a previous NPORT-P on November 29, 2024 disclosing 2,805 shares of AbbVie Inc.. This represents a change in shares of -97.15% during the quarter. The current value of the position is $18,178 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP AbbVie EC US00287Y1091 80 -2,725 -97.15 15 -97.47 0.0011
2024-11-29 2024-09-30 NP AbbVie EC US00287Y1091 2,805 0 0.00 554 14.97 0.0422
2024-08-27 2024-06-30 NP AbbVie EC US00287Y1091 2,805 -738 -20.83 481 -25.43 0.0379
2024-05-28 2024-03-31 NP AbbVie EC US00287Y1091 3,543 -2,995 -45.81 645 -36.33 0.0509
2024-02-27 2023-12-31 NP AbbVie EC US00287Y1091 6,538 5,304 429.82 1,013 453.55 0.0791
2023-11-27 2023-09-30 NP AbbVie EC US00287Y1091 1,234 914 285.62 184 325.58 0.0147
2023-08-28 2023-06-30 NP AbbVie EC US00287Y1091 320 -4,393 -93.21 43 -94.04 0.0034
2022-08-23 2022-06-30 NP AbbVie EC US00287Y1091 4,713 -1,733 -26.88 722 -30.94 0.0559
2022-05-27 2022-03-31 NP AbbVie EC US00287Y1091 6,446 0 0.00 1,045 19.72 0.0732
2022-02-23 2021-12-31 NP AbbVie EC US00287Y1091 6,446 1,270 24.54 873 56.27 0.0552
2021-11-23 2021-09-30 NP AbbVie EC US00287Y1091 5,176 -451 -8.01 558 -11.85 0.0342
2021-08-19 2021-06-30 NP AbbVie EC US00287Y1091 5,627 -4,224 -42.88 634 -40.62 0.0377
2021-05-25 2021-03-31 NP AbbVie EC US00287Y1091 9,851 0 0.00 1,066 1.04 0.0664
2021-02-05 2020-12-31 NP AbbVie EC US00287Y1091 9,851 0 0.00 1,056 22.39 0.0675
2020-11-25 2020-09-30 NP AbbVie EC US00287Y1091 9,851 -360 -3.53 863 -13.97 0.0596
2020-08-06 2020-06-30 NP AbbVie EC US00287Y1091 10,211 3,936 62.73 1,003 109.62 0.0640
2020-05-27 2020-03-31 NP AbbVie EC US00287Y1091 6,275 2,721 76.56 478 52.23 0.0318
2020-02-10 2019-12-31 NP AbbVie EC US00287Y1091 3,554 -5,035 -58.62 315 -51.69 0.0164
2019-11-26 2019-09-30 NP AbbVie EC US00287Y1091 8,589 8,589 650 0.0322
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.